Skip to main content

Published locations for First drug for MET+ NSCLC shows high response rates

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. First drug for MET+ NSCLC shows high response rates

User login

  • Reset your password
  • /content/first-drug-met-nsclc-shows-high-response-rates
  • /fedprac/article/228088/lung-cancer/first-drug-met-nsclc-shows-high-response-rates
  • /oncologypractice/article/228088/lung-cancer/first-drug-met-nsclc-shows-high-response-rates
  • /fedprac/avaho/article/228088/lung-cancer/first-drug-met-nsclc-shows-high-response-rates
  • /hematology-oncology/article/228088/lung-cancer/first-drug-met-nsclc-shows-high-response-rates
  • /chestphysician/article/228088/lung-cancer/first-drug-met-nsclc-shows-high-response-rates